Učitavanje...

Dehydroxymethylepoxyquinomicin (DHMEQ) can suppress tumour necrosis factor-α production in lipopolysaccharide-injected mice, resulting in rescuing mice from death in vivo

Dehydroxymethylepoxyquinomicin (DHMEQ), a new nuclear factor (NF)-κB inhibitor, has several beneficial effects, including the suppression of tumour growth and anti-inflammatory effects. DHMEQ can also suppress the production of tumour necrosis factor (TNF)-α induced by lipopolysaccharide (LPS) in vi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Shimo, T, Adachi, Y, Umezawa, K, Okigaki, M, Takaya, J, Taniuchi, S, Ikehara, S, Kaneko, K
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2011
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3219905/
https://ncbi.nlm.nih.gov/pubmed/21985376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2011.04475.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!